This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Oct;112(5):661-663.

doi: 10.23736/S0026-4806.20.06479-4. Epub 2020 Mar 12.

miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6

Hui Li¹, Weiran Xu², Tian Wang³, Chengfan Yu³, Xiaosong Rao⁴, Xin Hong³, Xiaofeng Wang³

Affiliations

Affiliations

¹ Department of Urologic Surgery, Peking University International Hospital, Beijing, China - look_aya@163.com.
² Department of Internal Medicine-Oncology, Peking University International Hospital, Beijing, China.
³ Department of Urologic Surgery, Peking University International Hospital, Beijing, China.
⁴ Department of Pathology, Peking University International Hospital, Beijing, China.

PMID: 32166936
DOI: 10.23736/S0026-4806.20.06479-4

miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6

Hui Li et al. Minerva Med. 2021 Oct.

. 2021 Oct;112(5):661-663.

doi: 10.23736/S0026-4806.20.06479-4. Epub 2020 Mar 12.

Authors

Hui Li¹, Weiran Xu², Tian Wang³, Chengfan Yu³, Xiaosong Rao⁴, Xin Hong³, Xiaofeng Wang³

Affiliations

¹ Department of Urologic Surgery, Peking University International Hospital, Beijing, China - look_aya@163.com.
² Department of Internal Medicine-Oncology, Peking University International Hospital, Beijing, China.
³ Department of Urologic Surgery, Peking University International Hospital, Beijing, China.
⁴ Department of Pathology, Peking University International Hospital, Beijing, China.

PMID: 32166936
DOI: 10.23736/S0026-4806.20.06479-4

No abstract available

PubMed Disclaimer

Similar articles

MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.
Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L, Liu Y, Gao Y, Xu D, Wang Q. Qu F, et al. Mol Cell Biochem. 2013 May;377(1-2):121-30. doi: 10.1007/s11010-013-1576-z. Epub 2013 Feb 17. Mol Cell Biochem. 2013. PMID: 23417242
MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer.
Zhang X, Xiao D, Wang Z, Zou Y, Huang L, Lin W, Deng Q, Pan H, Zhou J, Liang C, He J. Zhang X, et al. Mol Cancer Res. 2014 Nov;12(11):1535-46. doi: 10.1158/1541-7786.MCR-13-0641. Epub 2014 Aug 6. Mol Cancer Res. 2014. PMID: 25100863
MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
Kong Q, Chen XS, Tian T, Xia XY, Xu P. Kong Q, et al. Oncol Rep. 2017 Feb;37(2):803-812. doi: 10.3892/or.2016.5305. Epub 2016 Dec 8. Oncol Rep. 2017. PMID: 27959429
Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
Guo K, Zheng S, Xu Y, Xu A, Chen B, Wen Y. Guo K, et al. Tumour Biol. 2016 Sep;37(9):12843-12854. doi: 10.1007/s13277-016-5158-z. Epub 2016 Jul 23. Tumour Biol. 2016. PMID: 27449037
microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
Kong X, Qian X, Duan L, Liu H, Zhu Y, Qi J. Kong X, et al. DNA Cell Biol. 2016 Dec;35(12):828-835. doi: 10.1089/dna.2015.3186. Epub 2016 Sep 27. DNA Cell Biol. 2016. PMID: 27673408 Free PMC article.

See all similar articles

Cited by

Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications.
Ziegler JN, Tian C. Ziegler JN, et al. Int J Mol Sci. 2023 Oct 15;24(20):15206. doi: 10.3390/ijms242015206. Int J Mol Sci. 2023. PMID: 37894887 Free PMC article. Review.
LINC01088/miR-22/CDC6 Axis Regulates Prostate Cancer Progression by Activating the PI3K/AKT Pathway.
Li J, Huang X, Chen H, Gu C, Ni B, Zhou J. Li J, et al. Mediators Inflamm. 2023 Jul 19;2023:9207148. doi: 10.1155/2023/9207148. eCollection 2023. Mediators Inflamm. 2023. PMID: 37501932 Free PMC article.
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease.
Guan W, Chen Y, Fan Y. Guan W, et al. Curr Med Chem. 2024;31(18):2550-2570. doi: 10.2174/0109298673271808231116075056. Curr Med Chem. 2024. PMID: 38204224 Review.
An in-silico approach leads to explore six genes as a molecular signatures of lung adenocarcinoma.
Abdel-Maksoud MA, Hassan F, Mubarik U, Mubarak A, Farrag MA, Alghamdi S, Atuahene SA, Almekhlafi S, Aufy M. Abdel-Maksoud MA, et al. Am J Cancer Res. 2023 Mar 15;13(3):727-757. eCollection 2023. Am J Cancer Res. 2023. PMID: 37034228 Free PMC article.

Publication types

Actions

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Minerva Medica
Medical
- MedlinePlus Health Information